Shouguang Fukang Pharmaceutical Co. Ltd
Shouguang Fukang Pharmaceutical Co. Ltd., a prominent player in the pharmaceutical industry, is headquartered in Shouguang, China. Established in 1998, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong focus on research and innovation, Shouguang Fukang has developed a diverse portfolio that includes both generic and proprietary drugs, setting itself apart through rigorous quality control and adherence to international standards. The company has earned a solid market position, recognised for its commitment to excellence and customer satisfaction. Operating primarily in Asia, Shouguang Fukang continues to expand its reach, contributing to the global healthcare landscape with its unique offerings and dedication to improving patient outcomes.
DitchCarbon Score
How does Shouguang Fukang Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shouguang Fukang Pharmaceutical Co. Ltd's score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shouguang Fukang Pharmaceutical Co. Ltd's reported carbon emissions
Shouguang Fukang Pharmaceutical Co. Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Shouguang Fukang Pharmaceutical Co. Ltd appears to lack formal commitments to address carbon emissions or climate change initiatives at this time. This absence of data may reflect a broader trend within the pharmaceutical industry, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for emissions reductions. Without specific emissions data or reduction initiatives, it is challenging to assess the company's environmental performance or its alignment with industry standards for sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shouguang Fukang Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
